Managing asthma often requires a two-pronged approach — long-term medicines to prevent attacks and rescue strategies to stop attacks when they happen. It’s important to avoid triggers and monitor ...
Early Phase I data showed inhaled londamocitinib reduced airway inflammation in mild asthma with good tolerability. Learn ...
Biological drugs have been a game-changer for people with severe asthma, helping them breathe easier and live more comfortably. But researchers at Karolinska Institutet have uncovered a surprising ...
A monthly injection for managing severe asthma could help patients safely reduce or even discontinue daily steroid ...
Apogee Therapeutics, Inc. (NASDAQ: APGE) on Tuesday shared interim data from the Phase 1b trial of zumilokibart (APG777) in patients with mild-to-moderate asthma. The data covers 19 adult patients ...
A man with asthma, an Asian man at home sitting on the couch breathing in an inhaler An anti-inflammation injectable can help asthma patients with airways clogged by mucus The number of patients with ...
Hosted on MSN
Life-saving asthma drug taken twice a year slashes hospital admissions by three-quarters
A twice-yearly injection that could prevent thousands of asthma patients from suffering life-threatening attacks will go on sale in Britain within months. Trials show the ‘ultra-long-acting’ drug, ...
People taking GLP-1 medications had better-controlled asthma overall, though there was no difference in lung function compared to those not taking GLP-1s. The study suggests that GLP-1 drugs may have ...
The policy shift has prompted safety concerns from doctors and patient advocates.
Bulletin: ...WINTER WEATHER ADVISORY IN EFFECT FROM 4 AM TO 10 AM EST TUESDAY... * WHAT...Snow expected. Total snow and sleet accumulations between 1 and 3 inches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results